Canadian grants & funding programs

Cooperative Agriculture

The objectives for the use of cooperative agriculture in the National Wildlife Refuge System (NWRS) are: production or modification of specific cover types or growing methods that meet the life history requirements of species for which we have established objectives (e.g., waterfowl production); production of foods for wildlife species for which we have established objectives; and/or maintenance, rehabilitation, or reestablishment of natural habitat. Cooperative agriculture is when a person or entity conducts agricultural practices on NWRS lands in support of the Service conservation and resource management objectives and there is substantial involvement between the Service and that person or entity. The NWRS uses cooperative agreements, known as Cooperative Agriculture Agreements (CAAs), as the legal instruments to formalize the agreement between the Service and the program participant. The cost-sharing of a person or entity in cooperative agricultural on NWRS lands can vary depending on the needs and objectives of the particular NWRS land. For example, the Service may provide the cooperator with the right to perform agricultural practices on NWRS land and a percentage of any resulting crop yield, as well as the ability to use Service water, equipment, and/or refuge staff. In exchange, the cooperator may provide the Service with labor, equipment, and materials; a percentage of any resulting crop yield; and/or maintenance, rehabilitation, or reestablishment of specific habitat conditions on NWRS lands. In addition to or instead of cost-sharing, the Service may accept bids for payment for the person or entity agriculture use (e.g. haying or grazing) on NWRS lands in compliance with the Refuge Revenue Sharing Act. This is a nonfinancial assistance program. No Federal funds are obligated or awarded to program participants. . . This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. The program will post an annual Notice of Participation Opportunity on Grants.gov. The annual notice will provide a link to the NWRS website where individual cooperative agricultural opportunities will be posted as they become available (https://www.fws.gov/refuges/whm/cooperativeAgriculture.html/).. . Individual cooperative agriculture opportunities will also be advertised through other national, regional, and local outreach channels as determined by the Service to be appropriate. The notice for each new opportunity will include a general description of the opportunity, the objective criteria the Service will use to evaluate applicants, the application due date, and application instructions.. . Individual cooperative agriculture agreements can be approved for a period of a few months or up to a period of 5 years. Once that period ends, the Service will determine if those same cooperative agriculture activities should continue. If the Service will continue those same cooperative agriculture activities, a new individual cooperative agriculture opportunity will be posted on the NWRS website and made available for eligible entities to apply. . . Because a CAA is not a financial assistance award, it is not subject to the regulations at 2 CFR 200 or policy in parts 515 and 516 of the Fish and Wildlife Service Manual. CAA's issued under this Notice of Opportunity are entered into under the U.S. Fish and Wildlife Service's (Service)'s CFDA (15.681) under the authority of the Fish and Wildlife Coordination Act (16 U.S.C. 661-667e); Migratory Bird Conservation Act (16 U.S.C. 715); National Wildlife Refuge System Administration Act, as amended by the National Wildlife Refuge System Improvement Act (16 U.S.C. 668dd); Refuge Revenue Sharing Act (16 U.S.C. 715s); National Wildlife Refuge System Regulations, Economic Uses and Cooperative Land Management (50 CFR 29.1-2); and Department of Interior Policy, 505 Departmental Manual (DM) 2, Procurement Contracts, Grant and Cooperative Agreements.

United States

Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional)

Reissue of RFA-MH-19-240. This Funding Opportunity Announcement (FOA) solicits proposals for research projects that will apply computational approaches to develop parametrically detailed behavioral assays across mental-health relevant domains of function. These projects should focus on behavior in humans and test computational models in healthy subjects. For future applications, NIMH is particularly interested in behavioral measures, models, and parameters that have the potential for back-translation from humans to animals, especially for pre-clinical therapeutics development. NIMH is also interested in models that can be extended to clinical populations in the future.

United States

Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)

The objective of the NIH Career Transition Award (K22) is to provide support to outstanding basic or clinical investigators to develop their independent research skills through a two phase program: an initial period involving an intramural appointment at the NIH and a final period of support at an extramural institution. This NINDS K22 is specifically designed to facilitate the transition of NINDS intramural neurologist- and neurosurgeon-scientists to independent, academic faculty positions that support clinician-scientists to engage in independently funded scientific research as well as clinical activities.

United States

Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)

The NIH ?Research With Activities Related to Diversity (ReWARD) Program's overarching goal is to enhance the breadth and geographical location of research and research-related activities supported by NIH. The ReWARD program provides support for the health-related research of scientists who are making a significant contribution to Diversity, Equity, Inclusion, and Accessibility (DEIA) and who have no current NIH research project grant funding. The ReWARD program provides funding for both the scientific research and the DEIA activities of investigators. The grant will support scientific research in areas related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) and ongoing DEIA activities focused on enhancing diversity in the biomedical research enterprise within the United States and territories.

United States

Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)

Through this I-Corps at NIH program Funding Opportunity Announcement (FOA), NIH and CDC provide administrative supplement awards to active SBIR (NIH and CDC) and STTR Phase I (NIH only) grantees/awardees. The I-Corps at NIH mission is to empower entrepreneurs in developing and validating a strategic business model through diverse customer discovery in order to meet unmet clinical needs. I-Corps enables and accelerates the transformation of invention to impact SBIR and STTR Phase I awardees in a no-cost extension are eligible as long as, if selected, their no cost extension covers the entire duration of I-Corps at NIH cohort. The program provides three-member project teams with access to instruction and mentoring to accelerate the translation of technologies currently being developed with NIH and CDC SBIR and STTR funding. It is anticipated that outcomes for the I-Corps teams participating in this program will include significantly refined commercialization plans and well-informed pivots in their overall commercialization strategies. Prospective applicants are strongly encouraged to contact Scientific/Research staff for more information about the program before applying.

United States

Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) seeks to stimulate HIV/AIDS research within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that align with the HIV/AIDS research priorities outlined by the NIH Office of AIDS Research (OAR). These priorities were most recently described in NOT-OD-20-018 UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

United States

OCI Customer Demonstration Program

75% funding for technology development, marketing, and collaboration to boost your business.

The Customer Demonstration Program provides Ontario government grants to support technology demonstrations between two or more Ontario-based businesses. Through the program, funding will be awarded for innovative “market disruptors” to demonstrate the value of smart computing products/services to a “receptor” who can purchase and adopt the technology. This helps overcome commercialization barriers and helps generate a business case for wide-scale adoption.

Ontario

T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed)

The purpose of this funding opportunity announcement (FOA) is to enhance the participation of individuals from nationally underrepresented backgrounds in cardiovascular, pulmonary, hematologic and sleep disorders research across the career development continuum by providing support to institutions that promote diversity. The NHLBI's T32 Training Program for Institutions That Promote Diversity is a Ruth L. Kirschstein National Research Service Award Program intended to support training of predoctoral and health professional students and individuals in postdoctoral training institutions with an institutional mission focused on serving health disparity populations not well represented in scientific research, or institutions that have been identified by federal legislation as having an institutional mission focused on these populations, with the potential to develop meritorious training programs in cardiovascular, pulmonary, and hematologic diseases, and sleep disorders. These institutions are uniquely positioned to engage minority and other health disparity populations in research, translation, and implementation of research advances that impact health outcomes, as well as provide health care for these populations. This FOA does not allow appointed trainees to lead an independent clinical trial but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.

United States

Notice of Intent to Publish a Funding Opportunity Announcement for Transforming NHGRIÔř?s Diversity Action Plan (R25 Clinical Trials Not Allowed)

The purpose of this Notice is to alert the community that NHGRI plans to publish a Funding Opportunity Announcement (FOA) to transform NHGRIÔř?s Diversity Action Plan (R25 Clinical Trials Not Allowed) to better align with more recent NHGRI efforts to enhance workforce diversity.. Background. Recent strategic planning undertaken at NHGRI underscores the commitment to genomic workforce diversity, as described in the 2020 NHGRI Strategic Vision, the NHGRI Action Agenda for Building a Diverse Genomic Research Workforce, and the NHGRI Training Task Force Report presented to the National Advisory Council for Human Genome Research in February, 2020.. As described in the NHGRI DirectorÔř?s letter in the 2021 NHGRI Action agenda, data show that enhancing the diversity of scientific teams produces better ideas and more creativity. Developing teams of individuals from diverse backgrounds, however, means recognizing that some groups are underrepresented in the biomedical workforce. These groups include individuals from underrepresented racial and ethnic groups, individuals with disabilities, individuals from disadvantaged backgrounds, and women in staff, faculty, and leadership positions in the biomedical, clinical, behavioral, and social sciences research enterprises as well as in healthcare professions.Toward that end, NHGRI is committed to training, employing, and retaining a diverse genomics workforce, by supporting pathways that help diverse groups of individuals develop the skills and knowledge to pursue a career in genomics.. Since 2002, the Diversity Action Plan (DAP) program has supported over 600 undergraduate, post-baccalaureate and graduate trainees to participate in research experiences and courses, with the goal to help transition them to the next stage of their research career in a genomics-related field. These individuals have represented diverse groups, including those identified as underrepresented in the biomedical, clinical, behavioral and social sciences, as described in the Notice of NIHÔř?s Interest in Diversity, NOT-OD-20-031. As described in the Notice, research shows that diverse teams working together and capitalizing on innovative ideas and distinct perspectives outperform homogenous teams. Scientists and trainees from diverse backgrounds and life experiences bring different perspectives, creativity, and individual enterprise to address complex scientific problems.. Additional assessment is needed to evaluate the unique contributions of the DAP to NHGRIÔř?s diversity-related training portfolio. In recent years, NHGRI has supported new initiatives and programs focused on enhancing diversity, including, but not limited to, the Genome Research Experiences to Attract Talented Undergraduates into the Genomics Field to Enhance Diversity, Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity, and NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce. . This Notice is being provided to inform the community that NHGRI is transforming the DAP program to continue training a diverse group of individuals who are well prepared to tackle the challenges in genomics, while aligning more strongly with current NHGRI strategic objectives. The FOA is expected to be published in Summer, 2023 with an expected application due date in Early 2024.. This FOA will utilize the R25 activity code. Details of the planned FOA are provided below.

United States

NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Basic Experimental Studies Involving Humans Required)

The purpose of the NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22) program is to provide highly qualified dentists in NIH Intramural postdoctoral fellowship positions with opportunity to transition from mentored research experiences in the NIH Intramural program to extramural institutions as new investigators with independent research funding.

United States

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) invites research grant applications that propose the preclinical development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in rodent and nonhuman primate brain and incorporation of pilot or clinical feasibility evaluation in pre-clinical studies and appropriate model development. Projects proposing clinical assessments of novel radioligands should respond to FOA PAR XX-XXX .

United States

Pragmatic Trials for Dementia Care and Caregiver Support (R61/R33 Clinical Trial Required)

This Funding Opportunity Announcement(FOA) will support pragmatic trials within Stage IV of the NIH Stage Model to improve dementia care across multiple dementia care settings that will: (1) be designed to address practical comparative questions faced by Alzheimers disease (AD) and AD-related dementia (ADRD) patients, clinicians, and caregivers (both paid and unpaid); (2) include broad and diverse populations; and (3) be conducted in real-world settings with adequate sample size. These trials are intended to produce results that can be directly adopted by healthcare providers, patients, or caregivers for rapid dissemination and implementation. Successful applications will: (1) improve quality of care of persons with dementia; (2) improve quality of life for persons with dementia and their informal caregivers; (3) deliver more patient-focused, cost-effective care across multiple settings; and/or (4) reduce disparities in dementia care.

United States

Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)

The goal of this Funding Opportunity Announcement (FOA) is to support translational research that provides strong justification for later-phase therapeutics discovery and development efforts in health-related outcomes relevant to the National Institute of Diabetes and Digestive and Kidney Diseases. This includes outcomes relevant to obesity, diabetes and related aspects of endocrinology and metabolism, digestive diseases, liver diseases, nutrition, kidney and urological diseases, and hematology. Additional information concerning programmatic areas at NIDDK is available a www.niddk.nih.gov/research-funding/research-programs/Pages/default.aspx and applicants are strongly encouraged to discuss research priorities with the Scientific Contact.

United States

National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders or Alcohol Use Disorder (U19 Clinical Trial Optional)

Reissue of PAR-20-119. This FOA encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimulation approaches to treat mental disorders, substance use disorders (SUDs) or alcohol use disorder (AUD), and to develop novel ligands and circuit-engagement devices as tools to further characterize existing or to validate new drug/device targets. Partnerships between academia and industry are strongly encouraged. This FOA supports a research program of multiple projects directed toward a specific major objective, basic theme or program goal, requiring a broadly based, multidisciplinary and often long-term approach. Projects seeking support for a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies should consider the companion U01 FOA.

United States

Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) encourages grant applications to support cancer epidemiology research in established cohort studies, defined as studies that have achieved their initial planned recruitment goal. Applications must include hypothesis-based research using data from an established cohort study and are expected to include support for cohort maintenance, continued follow-up, and sharing of the existing resources in addition to addressing research questions across the cancer control continuum.

United States

NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)

This FOA invites applications for investigator-initiated, high-risk multi-center observational studies involving more than one clinical center. Proposed studies should be hypothesis-driven and focus on a disease relevant to the mission of NIDDK. Planning activities must be completed prior to submission and are not permitted under this FOA. Applicants who require a planning phase may first apply for an implementation planning cooperative agreement (U34; see TEMP9971).Consultation with NIDDK Scientific/?R?e?s?e?a?r?c?h staff is strongly encouraged prior to the submission of either a U34 or U01 application.

United States

RFI-Counter-Trafficking in Persons in DRC

The USAID Mission in the DRC is in the process of designing a new Counter-Trafficking in Persons (C-TIP) Activity. By issuing this Request for Information (RFI), USAID/DRC aims to consult with the broad community of private sector actors, public institutions, development partners, non-governmental organizations, industry associations, civil society, think tanks, and academia concerned with C-TIP in DRC.

United States

Fostering Research With Additional Resources and Development (FORWARD) Urology Centers (P20 Clinical Trial Not Allowed)

The overall goal of the Fostering Research with Additional Resources and Development (FORWARD) Urology Centers program is to foster and expand the urology (excluding cancer) research community. The objective of each FORWARD Urology Center will be to support a Research Project designed and conducted by a collaborative, multidisciplinary team comprising primarily of junior investigators with at least one Early Stage Investigator (ESI) and/or researcher new to urology. Research Project data are expected to support one or more follow-on independent grant applications (e.g., R01s) submitted by Research Project Team investigators. The Center PD(s)/PI(s) will lead an Administrative (Project Support) Core to provide guidance to the Research Project Team to help ensure the research aims are met and to aid them in their successful integration into the broader urologic research field. The Center will leverage intra- and extra-institutional resources, collaborations and facilities and engage as a member of NIDDKs CAIRIBU (Collaborating for the Advancement of Interdisciplinary Research in Benign Urology) Program.

United States

Limited Competition: High Quality Reference Genomes (UM1 Clinical Trial Not Allowed)

The National Human Genome Research Institute (NHGRI) will renew the NHGRI Human Genome Reference Program (HGRP). This FOA seeks applications for the production of High Quality Human Reference Genomes (HQRG) as one of three components of the renewed HGRP. The HQRG component will lead the prioritization and selection of samples from diverse participants consented for open access data release, and, with those samples, produce 200 new, very high-quality haplotype-resolved human genome assemblies for inclusion in the human pangenome reference. The HQRG component will also include a team of ethical, legal and social issues scholars who will be embedded in the overall HGRP. This team will be integrated with the consortium to help identify and navigate topics raised by the development of a human pangenome resource, including consent, data release and sovereignty, definitions of diversity, and others that may arise over time. This is a limited competition RFA. Only recipient organizations funded under RFA-HG-19-002 are eligible to apply.

United States

Programme de soutien aux partenariats en francisation

75% funding for promoting French in workplaces, signage, and customer service.

The Program supports projects aimed at promoting the use of French in the public space and in Quebec workplaces, and the mastery of French terminology in a specific field of activity.

Quebec

Roulez Vert – Rebate for charging station at work

50% funding for workplace electric vehicle charging stations and installation costs.

Reimbursement for Quebec businesses, municipalities and public bodies of up to $49,000 per eligible building per fiscal year for the purchase and installation of electric vehicle charging stations at your workplace for employees.

Quebec

Mitacs Business Innovation Internship

Provides $15,000 per 4-month internship (up to 3 internships) to hire graduate students and postdocs for innovation projects. Helps offset salary costs while accessing specialized talent.

Canada

Sustainable Growth Investment – Young Entrepreneurs

70% funding for sustainable investments, covering interest costs and liquidity needs.

The Sustainable Growth Investment Program has been in effect since June 17, 2022. It ensures the continuity of the Growth Investment Program. This program was put in place for farmers who have investment projects to put forward, regardless of their production sector or which life cycle their business is in. It aims to support productive and sustainable investments. The financial assistance consists of an investment grant conditional on a loan guarantee from La Financičre agricole. The maximum amount of eligible financing per business is $700,000. Assistance is paid out over a three-year period.

Quebec

Market Development and Access

50% funding for market access, trade shows, and consumer engagement in food industry.

Gain access to financial support to cover the costs of activities aimed at supporting industry efforts to access and take advantage of new, existing, and emerging market opportunities, from local farmers' markets to international markets.

New Brunswick

Mitacs Accelerate International

50% funding for research, travel, and international collaboration to boost your business.

Mitacs Accelerate International provides funding starting at $15,000 to support bilateral research collaborations between interns and organizations in Canada and other partner countries.

Canada

Labour Force Training

The webpage did not provide specific details about the grant's offerings, such as the percentage of funding or the eligible expenses. Therefore, I cannot create an accurate tagline based on the information available. If you have specific details about the grant, please share them, and I can help you craft a tagline.

The Labour Force Training program’s objective is to provide funding to eligible businesses and organizations which may assist in the training of existing employees so that they may develop the necessary skills to increase, improve and/or maintain labour market attachment.

New Brunswick

TechBC Venture Acceleration Program

Supports BC tech companies in scaling operations through mentorship, market access, and up to $40,000 in non-dilutive funding for growth initiatives.

British Columbia

International Promotion Program

75% funding for international festivals, promotion campaigns, and Telefilm initiatives.

The International Promotion Program offers financial support for participation and attendance for international festivals, forums and events, international promotion campaigns, and Telefilm-invited international initiatives.

Canada

Immigrant Investor Program

A non-repayable contribution of $40,000 to $250,000, and covering up to 10% of project costs, is available for initiatives to expand, modernize, enhance production, and more.

Quebec

Organic Industry Development – Increasing Market Competitiveness

50% funding for equipment, land conversion, and market development in organic agriculture.

Up to $40,000 to cover 50% of the costs related to implementing technologies to meet organic market requirements, improve efficiency or modify a facility to meet certified organic requirements

Prince Edward Island

Invest Nova Scotia – Greenshoots

90% funding for agri-tech, clean tech, and bioeconomy innovations. Boost your growth.

GreenShoots aims to support early stage technology companies in agriculture, agri-food, bioeconomy, clean technology, and related sectors in Nova Scotia. Successful applicants receive up to $40,000 in non-repayable, non-dilutive funding, as well as business guidance to put their plans into action. The goal is to find and support high potential, early stage knowledge-based Nova Scotia companies and encourage entrepreneurial activity in the province.

Nova Scotia

Green Industrial Facilities and Manufacturing Program – ISO 50001 Financial Assistance

Up to 50% of eligible ISO 50001 implementation and certification costs, up to $40,000 per facility.

NRCan funding to support industrial facilities in adopting ISO 50001 energy management systems, including training, metering, and certification costs.

Canada

Video

50% funding for music video production, elevate your artistry and reach new audiences.

The Video program contributes to the cost of producing music videos for eligible Canadian sound recordings by artists rated 2 and 3.

Canada

Organic Industry Development Program

50% funding for organic equipment, market development, and land conversion projects.

The Organic Industry Development Program supports organic producers and processors in Prince Edward Island with strategic assistance to increase their capacity, growth, and competitiveness.

Prince Edward Island

Compensation for Employers of Reservists Program

75% funding for operational costs when reservists deploy on military duty.

The Compensation for Employers of Reservists Program provides a one-time financial support to civilian employers of reservists and self-employed reservists, aims to enhance relationships with civilian employers, enable reservists to be more fully integrated alongside the Canadian Armed Forces Regular Force, and establish greater awareness and promotion of the work of the Reserve Force among civilian employers, educational institutions and throughout Canadian communities

Canada

Compensation for Employers of Reservists

75% funding for operational costs when reservists deploy on military duty.

The Compensation for Employers of Reservists Program provides a one-time financial support to civilian employers of reservists and self-employed reservists, aims to enhance relationships with civilian employers, enable reservists to be more fully integrated alongside the Canadian Armed Forces Regular Force, and establish greater awareness and promotion of the work of the Reserve Force among civilian employers, educational institutions and throughout Canadian communities

Canada

Development program – Black and People of Colour stream

Up to 75% funding for script development, packaging, and project enhancement.

The Development Program finances Canadian feature films at the development stage. The Development Program has four streams: Prequalified Stream, General Stream, Indigenous Stream, and Stream for Black and People of Colour.

Canada

Development program – Indigenous stream

Up to 75% funding for script development, packaging, and project strengthening.

The Development Program finances Canadian feature films at the development stage. It has four streams: Prequalified Stream, General Stream, Indigenous Stream, and Stream for Black and People of Colour. Telefilm will be launching a pilot initiative called the Springboard Initiative in summer 2024.

Canada

Development program – General stream

75% funding for script development, project packaging, and talent support.

Get a repayable advance of up to $37,500 in the development stage of your feature film. To be eligible, you need to have released at least 1 fictional or documentary feature film in the last 6 years, and 1 film that premiered at a qualifying festival.

Canada

Mentored Career Development Program for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to provide early-stage investigators with support and protected time (up to five years) for intensive, research-focused career development program activities under the guidance of an experienced mentorship team with expertise in both the preclinical application of nonhuman primate (NHP) models and in translation of the results from such studies to clinical application. The focus of this program is to increase the number of highly skilled scientists using NHP models to address complex translational biomedical research designed to foster translation of outcomes into the clinic. The expectation is that through this sustained period of research career development and training, awardees will launch independent research careers and become competitive for new research project grant (e.g., R01) funding.. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.

United States

NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)

This Notice of Funding Opportunity (NOFO) solicits grant applications for the preparation of book-length manuscripts and other works of academic and/or public health importance to U.S. health professionals, public health officials, biomedical researchers and historians of the health sciences.

United States

Maximizing the Scientific Value of the NHLBI Biologic Biospecimen Repository: Scientific Opportunities for Exploratory Research (R21)

This Funding Opportunity Announcement (FOA) will support meritorious exploratory research relevant to the NHLBI mission (http://www.nhlbi.nih.gov/about/org/mission) using the existing biospecimen collections that are stored in the NHLBI Biologic Specimen Repository (Biorepository), thereby maximizing the scientific value of the stored collections and providing researchers with an opportunity to generate preliminary data for subsequent research proposals.

United States

Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) announces a program that provides NIDDK-supported K01, K08, K23, and K25 recipients the opportunity to apply for Small Grant (R03) support at some point during the latter years of their award period of their K award. Through the use of this mechanism, the NIDDK is seeking to enhance the capability of its K01, K08, K23, and K25 award recipients to conduct research as they complete their transition to fully independent investigator status. The R03 grant mechanism supports different types of projects, including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is, therefore, intended to support research projects that can be carried out in a short period of time with limited resources and that may provide preliminary data to support a subsequent R01, or equivalent, application.

United States

Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) encourages Research Conference Grant (R13) applications to conduct an annual intensive workshop/conference/meeting that addresses the needs of early stage HIV/AIDS researchers utilizing nonhuman primates (NHPs) as they translate preclinical research from NHPs to human clinical trials. The objectives of the meeting(s) supported by this FOA are to provide these early stage HIV/AIDS researchers with guidance on conducting preclinical research to inform clinical trials on reducing the incidence of HIV/AIDS infection, including vaccine development and testing; developing next-generation HIV therapies, including potential cure therapies; treatment of HIV-associated coinfections, comorbidities and complications; and infection prevention strategies. In addition to guidance on translating results to clinical trials, the conference should target developing skills related to networking, grantsmanship, and goal/milestone-driven projects. Conference topics should also include other considerations such as statistical and host genetics considerations; methods to translate the results of NHP studies to clinical trials in humans; and how to develop new NHP research programs to better reflect clinical observations and findings in human HIV/AIDS patients.

United States

Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)

The purpose of this funding opportunity announcement (FOA) is to solicit current or recently completed NHLBI K01, K08, K23, and K25 awardees for small grant support to expand their current research objectives or to branch out to a new study that resulted from the research conducted under the K award. Active NHLBI K01, K08, K23, and K25 awardees may apply for R03 support after the notices of award (NoA) for their first type-5 K awards have been issued. Recently completed NHLBI K01, K08, K23, and K25 awardees are eligible to apply for the R03 if the earliest possible R03 start date falls within 2 years of their prior NHLBI K award Project Period end date. This FOA is intended to enhance the capability of NHLBI K01, K08, K23, and K25 awardees to conduct research as they complete their transition to fully independent investigator status.. This R03 grant mechanism is intended to support research projects that can be carried out and completed within a short period of time (no more than two years) with limited resources and that may generate preliminary data to support a subsequent R01-equivalent application. These studies include, but not limited to, pilot or feasibility studies; proof of concept studies; secondary analysis of existing data; small, self-contained research projects; development of new research methodologies or technologies, or development of novel experimental models. For current and previous K23 awardees, research proposed in the R03 application may or may not include patient-oriented research. A minimum of 40% protected overall research effort is required from applicants during the R03 award period and can be met through a combination of effort on the proposed R03 and other research projects, regardless of funding source.

United States

Plant Your Roots Program

50% funding for new farm ownership, improving financial stability and growth.

The Plant Your Roots program supports new ownership of commercial farms in Nova Scotia. It helps improve the financial stability of beginner farmers.

Nova Scotia

Doctoral Research Award: Doctoral Foreign Study Award (DFSA): 2023-2024

75% funding for health research, knowledge translation, and commercialization projects.

The Doctoral Foreign Study Award (DFSA) program supports high-calibre students engaged in doctoral programs in all academic disciplines who are pursuing a doctoral degree in a health-related field abroad (outside of Canada).

Canada

Doctoral Research Award: Canada Graduate Scholarships Doctoral Award: 2023-2024

The Canada Graduate Scholarship Doctoral (CGS D) program supports and promotes research excellence in a wide variety of disciplines and broad fields of health, natural sciences and engineering, and social sciences and humanities, including interdisciplinary and multidisciplinary research. This support allows scholars to more fully concentrate on their doctoral studies, to seek out the best research mentors in their chosen fields and contribute to the Canadian research ecosystem during and beyond the tenure of their awards.

Canada